e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
COPD: symptoms and staging
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of symptomatology in patients with GOLD stage I COPD
P. Gagnon, D. Saey, S. Provencher, J. Milot, F. Maltais (Canada)
Source:
Annual Congress 2010 - COPD: symptoms and staging
Session:
COPD: symptoms and staging
Session type:
Oral Presentation
Number:
5548
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Gagnon, D. Saey, S. Provencher, J. Milot, F. Maltais (Canada). Impact of symptomatology in patients with GOLD stage I COPD. Eur Respir J 2010; 36: Suppl. 54, 5548
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Impact of comorbidities on survival of patients with COPD according to GOLD stages
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
GOLD assessment of COPD patients: Impact of symptoms assessment choice
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
High prevalence of osteoporosis in COPD patients independent of GOLD stage
Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010
Year: 2010
Effect of COPD severity on hemodynamic responses to exercise in patients with GOLD stages I-IV
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
GOLD stage 0 and risk of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 352s
Year: 2003
Anxiety and dyspnea relation in early stage COPD patients
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results
Source: Eur Respir J 2005; 26: Suppl. 49, 69s
Year: 2005
Comorbidities in stage IV COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011
Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002
Copeptin and GOLD stage are independent predictors of exertional desaturation in patients with COPD
Source: Annual Congress 2010 - Research development in exercise and gas exchange
Year: 2010
Effects of tiotropium on lung volumes during exercise in GOLD stage II to IV COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 171s
Year: 2006
COPD GOLD stage 1: Is it really a disease?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Prevalence and severity of GOLD defined COPD in adults
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002
The prevalence of QTc-prolongation increase by GOLD stage in COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
The effect of changing GOLD severity stage on long-term mortality in COPD
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Quality of life, stage severity and COPD
Source: Eur Respir J 2009; 33: 953-955
Year: 2009
Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept